Cai, ZC, Najib, S, Núñez-Sánchez, MA, Martínez-Sánchez, MA, García-Melgares, C, Viguerie, N, Rossell, J, Julve, J, Croyal, M, Oliveira, AR, Martínez, CM, Dumas, SJ, Genoux, A, Frutos, MD, Ramos-Molina, B, Martinez, LO. ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study. Lipids in Health and Disease. 2025; 24(1)DOI:10.1186/s12944-025-02733-0. PMID:41088161. IF:4.200(Q1/3D).

Torres-Méndez, JK, Rojo-López, MI, Antentas, M, Vendrell, P, Ortega, E, Alonso, N, Castelblanco, E, Muscarà, A, Rubinat, E, Alcubierre, N, Hernández, M, Rossell, J, Granado-Casas, M, Mauricio, D, Julve, J. Association between dietary niacin intake and diabetic retinopathy in a Catalonian population: a cross-sectional study. Frontiers in Nutrition. 2025; 12DOI:10.3389/fnut.2025.1626379. PMID:41164367. IF:5.100(Q1/2D).

León-Mengíbar, J, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Caixàs, A, Bueno, M, Ciudin, A, Hernández, M, Simó, R, Hernández, C, Lecube, A. Impact of the new EASO obesity definition on the detection of atheromatosis in subjects with low-to-moderate cardiovascular risk. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1689960. PMID:41141356. IF:4.600(Q1/3D).

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia (vol581, 112113, 2024). MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2025; 608DOI:10.1016/j.mce.2025.112626. PMID:40750504. IF:3.600(Q2/4D).

Ma, CX, Ma, XN, Li, HL, Mauricio, D, Fu, SB. Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02938-8. PMID:41035032. IF:10.600(Q1/1D).

Alarcón, PP, Alvarez, ED, Goitia, CL, Rodríguez, MM, Urbon, L, Maldonado, A, García, S, Serrallonga, NB, Aviño, LR, Palomar, JMR, Lopez, JG, Hoyas, CIN, Corcoy, R, Raimond, TM, López, ML, Madorell, BS, Hernández, M, Kyriakos, G, Bellas, LC, Borrás, JG, Servant, OS, Colet, AM, Serrano, C, Contreras, C, Román, AR, Díez, M, Veladesojo, A, Andujar, P, Diez, A, Galiana, PA, Peris, BP, Fernandez, E, Ferrer, M, Alfonso, FJG, Torre, ELM. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study. Diabetes Technology & Therapeutics. 2025; 27(10)DOI:10.1177/15209156251363452. PMID:40729095. IF:6.300(Q1/2D).